An autism brain imaging study published seven years ago received an expression of concern last month after its authors failed to uphold a promise to make their raw data freely available.

Despite the growing interest in alexithymia in autism research, the tools commonly used to measure this trait may not work reliably in autistic populations. A new scoring method fills that gap.

After a study revised a popular measure for alexithymia, it was pulled for copyright infringement because the authors did not pay a $40 fee or obtain permission to use the measure.

In this edition of Null and Noteworthy, researchers rebut a controversial epidural study, test out autism assessments in toddlers and give the okay for multilingualism in autistic children.

A novel method to evaluate the strength of the evidence linking autism to specific genes could reveal which ones are most useful to screen for.

The coronavirus pandemic forced researchers and clinicians to find new ways to assess children for autism — many of which will almost certainly endure.

The U.K. clinical guidelines used to screen for autism contain an error, which may have resulted in many delayed or missed diagnoses over the past decade.

Blood levels of PTEN protein and associated molecules could eventually help diagnose autism and other neurological conditions — and predict their outcomes.

Researchers expand on the already enormous progress made on the Human Proteome Project

Babies who are later diagnosed with autism have a sluggish brain response to sound on a universal newborn hearing screen.